Document is current

Any future updates will be listed below

Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

Crossref DOI link: https://doi.org/10.1007/s13300-019-0670-y

Published Online: 2019-07-18

Published Print: 2019-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark